UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

ALVR109, an off‐the‐shelf partially HLA matched SARS‐CoV‐2–specific T cell therapy, to treat refractory severe COVID‐19 pneumonia in a heart transplant patient: Case report

American journal of transplantation, 2022-04, Vol.22 (4), p.1261-1265

2022

Volltextzugriff (PDF)

Final Outcomes from a Phase 2 Trial of Posoleucel in Allogeneic Hematopoietic Cell Transplant Recipients

Blood advances, 2024-04

2024

Volltextzugriff (PDF)

Former Times

The New England journal of medicine, 1995-10, Vol.333 (16), p.1084-1085

Messinger, S

1995

Volltextzugriff (PDF)

ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022, Vol.22 (4), p.1261-1265

2022

Volltextzugriff (PDF)

How Educational Innovators Apply Diffusion and Scale-Up Concepts

Scaling Educational Innovations, p.81-104

Volltextzugriff (PDF)

RESPONSE SURFACE DESIGNS FOR SPECIFIED FACTOR LEVELS

STONEMAN, DAVID MCNEEL

1966

Volltextzugriff (PDF)

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Clinical cancer research, 2016-11, Vol.22 (22), p.5461-5471

2016

Volltextzugriff (PDF)

A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells

Methods (San Diego, Calif.), 2013-12, Vol.64 (2), p.137-143

2013

Volltextzugriff (PDF)

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles

Frontiers in immunology, 2020-08, Vol.11, p.1867-1867

2020

Volltextzugriff (PDF)

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

Communications biology, 2022-09, Vol.5 (1), p.897-897, Article 897

2022

Volltextzugriff (PDF)

Is patient experience of care associated with treatment choices for women with early-stage breast cancer?

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.289-289

2022

Volltextzugriff (PDF)

Associations of depression with hypertension and citizenship among U.S. adults: A cross-sectional study of the interactions of hypertension and citizenship

Preventive medicine reports, 2023-12, Vol.36, p.102523-102523, Article 102523

2023

Volltextzugriff (PDF)

Inoculum size effect in dimorphic fungi: extracellular control of yeast-mycelium dimorphism in Ceratocystis ulmi

Applied and Environmental Microbiology, 2004-03, Vol.70 (3), p.1356-1359

2004

Volltextzugriff (PDF)

Awareness of Alcohol and Cancer Risk and the California Proposition 65 Warning Sign Updates: A Natural Experiment

International journal of environmental research and public health, 2022-09, Vol.19 (19), p.11862

2022

Volltextzugriff (PDF)

Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy

Journal of clinical oncology, 2007-02, Vol.25 (6), p.675-681

2007

Volltextzugriff (PDF)

Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion

Clinical cancer research, 2005-11, Vol.11 (21), p.7851-7860

2005

Volltextzugriff (PDF)

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

The New England journal of medicine, 2010-07, Vol.363 (5), p.411-422

2010

Volltextzugriff (PDF)

Evaluation of Low-Grade Yellow-Poplar ( Liriodendron tulipifera ) as Raw Material for Cross-Laminated Timber Panel Production

Forest products journal, 2022-01, Vol.72 (1), p.1-10

2022

Volltextzugriff (PDF)

Abstract B023: Racial-ethnic disparities in the receipt of initial, cure-intended treatment for localized prostate cancer, SEER Medicare, 2004-2013

Cancer epidemiology, biomarkers & prevention, 2020-06, Vol.29 (6_Supplement_1), p.B023-B023

2020

Volltextzugriff (PDF)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

Journal for immunotherapy of cancer, 2016-12, Vol.4 (1), p.92-92, Article 92

2016

Volltextzugriff (PDF)

Evaluation of Low-Grade Yellow-Poplar (Liriodendron tulipifera) as Raw Material for Cross-Laminated Timber

Forest products journal, 2022-03, Vol.72 (1), p.1

2022

Volltextzugriff (PDF)

Evaluation of Low-Grade Yellow-Poplar {Liriodendron tulipifera) as Raw Material for Cross-Laminated Timber

Forest products journal, 2022-01, Vol.72 (1), p.1-10

2022

Volltextzugriff (PDF)

Inducible expression of cancer-testis antigens in human prostate cancer

Oncotarget, 2016-12, Vol.7 (51), p.84359-84374

2016

Volltextzugriff (PDF)

Cross-Laminated Timber Panels Produced from Low-Grade Yellow-Poplar Sorted by Structural Visual Grade

Forest products journal, 2023-03, Vol.73 (2), p.104-112

2023

Volltextzugriff (PDF)

Active Transportation Increases Adherence to Activity Recommendations

American journal of preventive medicine, 2006-09, Vol.31 (3), p.210-216

2006

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(38)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(12)
Male
(9)
Biological And Medical Sciences
(7)
Middle Aged
(6)
Oncology
(5)
Adult
(4)
Aged
(4)
Female
(4)
Immunotherapy
(4)
Medical Sciences
(4)
Prostate Cancer
(4)
Cancer
(3)
Clinical Trials
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
General & Internal Medicine
(3)
Immunology
(3)
Lipolysis
(3)
Liriodendron Tulipifera
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ALVR109, an off‐the‐shelf partially HLA matched SARS‐CoV‐2–specific T cell therapy, to treat refractory severe COVID‐19 pneumonia in a heart transplant patient: Case report

Final Outcomes from a Phase 2 Trial of Posoleucel in Allogeneic Hematopoietic Cell Transplant Recipients

Former Times

ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report

How Educational Innovators Apply Diffusion and Scale-Up Concepts

RESPONSE SURFACE DESIGNS FOR SPECIFIED FACTOR LEVELS

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

Is patient experience of care associated with treatment choices for women with early-stage breast cancer?

Associations of depression with hypertension and citizenship among U.S. adults: A cross-sectional study of the interactions of hypertension and citizenship

Inoculum size effect in dimorphic fungi: extracellular control of yeast-mycelium dimorphism in Ceratocystis ulmi

Awareness of Alcohol and Cancer Risk and the California Proposition 65 Warning Sign Updates: A Natural Experiment

Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy

Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Evaluation of Low-Grade Yellow-Poplar ( Liriodendron tulipifera ) as Raw Material for Cross-Laminated Timber Panel Production

Abstract B023: Racial-ethnic disparities in the receipt of initial, cure-intended treatment for localized prostate cancer, SEER Medicare, 2004-2013

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

Evaluation of Low-Grade Yellow-Poplar (Liriodendron tulipifera) as Raw Material for Cross-Laminated Timber

Evaluation of Low-Grade Yellow-Poplar {Liriodendron tulipifera) as Raw Material for Cross-Laminated Timber

Inducible expression of cancer-testis antigens in human prostate cancer

Cross-Laminated Timber Panels Produced from Low-Grade Yellow-Poplar Sorted by Structural Visual Grade

Active Transportation Increases Adherence to Activity Recommendations

Suchergebnisse filtern